Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions.
Faulkner SD. et al, (2023), Pharmaceut Med, 1 - 10
Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines.
Faulkner SD. et al, (2021), Ther Innov Regul Sci
Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action
Cavaller-Bellaubi M. et al, (2021), Therapeutic Innovation & Regulatory Science
Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study
Faulkner SD. et al, (2021), Health Expectations
Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
Le Cam Y. et al, (2018), Clinical Pharmacology and Therapeutics
Maximising value from a United Kingdom Biomedical Research Centre: study protocol
Greenhalgh T. et al, (2017), Health research policy and systems, 15
An assessment of implications of adaptive licensing for pharmaceutical intellectual property and regulatory exclusivity rights in the European Union
(2016), Clinical Pharmacology and Therapeutics, 100, 743 - 753
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways
Pani L. and Barker R., (2016), Clinical Pharmacology and Therapeutics, 100, 730 - 742
Brain mitochondrial oxidative metabolism during and after cerebral hypoxia-ischemia studied by simultaneous phosphorus magnetic-resonance and broadband near-infrared spectroscopy.
Bainbridge A. et al, (2014), Neuroimage, 102 Pt 1, 173 - 183